Glypican-1 antisense transfection modulates TGF-β-dependent signaling in Colo-357 pancreatic cancer cells
Junsheng Li(National Clinical Research Center for Digestive Diseases), Helmut Frieß(TUM Klinikum), Jörg Kleeff(University Hospital in Halle), Markus W. Büchler(Heidelberg University), Hany Kayed(University of Jordan), Klaus Felix(Heidelberg University), Murray Korc(University of California, Irvine), Roland Penzel(Heidelberg University)
Cited by 57
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k